Abstract
Greg Marchand, MD; Ahmed Taher Masoud, MD; Malini Govindan, MD; Kelly Ware, MS; Alexa King, BS; Stacy Ruther, BS; Giovanna Brazil, BS; Hollie Ulibarri, BS; Julia Parise, BS; Amanda Arroyo, BS; Catherine Coriell, BS; Sydnee Goetz, BS; Amitis Karrys, BS; Katelyn Sainz, MD
Highlights
These findings reflect a growing body of evidence of adverse birth outcomes associated with prenatal cannabis use
It is better to put safeguards to protect infant and child health outcomes in place prior to cannabis legalization rather than after the fact, which most states with cannabis legalization and commercialization have failed to accomplish
Author affiliations and article information are listed at the end of this article
Summary
These findings reflect a growing body of evidence of adverse birth outcomes associated with prenatal cannabis use. States that have legalized and commercialized cannabis must work to retroactively prioritize protection of neonatal health. We urge voters and policy makers to fully weigh the potential benefits of recreational cannabis legalization (in states that have yet to legalize) against the growing body of evidence on neonatal health outcomes.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
